Ajinomoto

PCI Pharma Services Acquires Ajinomoto Althea

PCI Pharma Services has completed its acquisition of Ajinomoto Althea, a CDMO subsidiary of Ajinomoto.

New Ammonia Synthesis Technology

Tsubame BHB was established in April of 2017 based on a new catalyst technology developed by Prof. em. Hideo Hosono at the Tokyo Institute of Technology (Tokyo Tech), which allows an ammonia process at lower temperature and pressure.

News

Ajinomoto in Talks with Metex on Animal Feed Unit

Japan’s Ajinomoto has entered into exclusive negotiations with French fermentation firm METabolic EXplorer to sell its entire stake in Ajinomoto Animal Nutrition Europe (AANE), based in Amiens, France. The company said the sale its part of a strategic reshaping of its portfolio and a restructuring of non-core businesses.

News

Countering Commoditization

Top-Feature

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

INOSIM GmbH

Predictive Simulation in Pharma Production

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Citrine

Operationalizing AI in Polymer Development: How Syensqo Is Scaling Impact with the Citrine Platform

SCIEX

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Article

Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Managm. Consult. Chemicals

Tsubame BHB Co., Ltd